FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives The Peptide Craze Ground Truths Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law Save Peptides Save Peptides